Global medical device firm Medtronic has launched its comprehensive minimally-invasive spinal fusion procedure, Mast Aligned, into the global market.

The procedure comprises several options to access the spine, including oblique lateral, interbody, navigation and biologics.

The Mast Aligned procedure uses the company’s multi-level percutaneous fixation system, CD Horizon Longitude II, which provides spinal stabilisation and correction as an adjunct to fusion in patients suffering with painful and function-limiting disorders in the middle and lower back.

“The procedure comprises several options to access the spine, including oblique lateral, interbody, navigation and biologics.”

The procedure can also be used with the Nim-Eclipse system, Stealthstation navigation and O-ARM imaging systems and the Powerease system designed for drilling, tapping and driving screws during spinal surgery.

Medtronic spinal business senior vice president and president Doug King said that through the launch of the procedure the company is extending the benefits of Mast-based therapies to patients with advanced-stage conditions.

“In doing so, the team is also extending the range of capabilities of a proven platform, the CD Horizon Solera spinal system,” King said.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“We look forward to coupling availability of the procedure and associated technologies with initiatives aimed at growing patient access, worldwide.”